Analog Devices Inc: Form 10-Q for the period ended Jul 30, 2022
Filed with the SEC on Aug 17, 2022 and accepted by EDGAR at Aug 17, 2022, 07:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-07-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-05-01 to 2022-07-30 | $3.11bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-10-31 to 2022-07-30 | $8.77bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-05-01 to 2022-07-30 | $1.07bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2021-10-31 to 2022-07-30 | $3.38bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-05-01 to 2022-07-30 | $2.04bn | us-gaap:GrossProfit |
| Gross profit | 9 months2021-10-31 to 2022-07-30 | $5.39bn | us-gaap:GrossProfit |
| Research and development | 3 months2022-05-01 to 2022-07-30 | $431.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-10-31 to 2022-07-30 | $1.28bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-05-01 to 2022-07-30 | $326.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-10-31 to 2022-07-30 | $929.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-05-01 to 2022-07-30 | $893.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-10-31 to 2022-07-30 | $2.18bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-05-01 to 2022-07-30 | $51.2m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-10-31 to 2022-07-30 | $152.7m | us-gaap:InterestExpense |
| Income tax | 3 months2022-05-01 to 2022-07-30 | $99.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-10-31 to 2022-07-30 | $238.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-05-01 to 2022-07-30 | $749.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-10-31 to 2022-07-30 | $1.81bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-05-01 to 2022-07-30 | $1.44 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-10-31 to 2022-07-30 | $3.45 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-05-01 to 2022-07-30 | $1.45 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-10-31 to 2022-07-30 | $3.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-05-01 to 2022-07-30 | 520,550,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-10-31 to 2022-07-30 | 525,652,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-10-31 to 2022-07-30 | $3.33bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-10-31 to 2022-07-30 | $394.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2021-10-31 to 2022-07-30 | $1.15bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2021-10-31 to 2022-07-30 | $1.76bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-07-30 | $1.52bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-07-30 | $4.69bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-07-30 | $50.35bn | us-gaap:Assets |
| Current liabilities | At period end2022-07-30 | $2.44bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2022-07-30 | $6.28bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2022-07-30 | $0 | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2022-07-30 | $36.64bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-07-30 | 514,341,531 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000006281-22-000224. Last ingested by Listed: Oct 27, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.